Durabolin Drug Interactions
Currently displaying a list of 88 drugs known to interact with Durabolin (nandrolone).
- 11 major drug interactions
- 77 moderate drug interactions
Medications known to interact with Durabolin
Note: Showing generic names only.
- acetohexamide
- anisindione
- ashwaganda
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- C1 esterase inhibitor (human)
- calaspargase pegol
- calcipotriene topical
- calcitriol topical
- cannabidiol
- carfilzomib
- chlorpropamide
- clofarabine
- conestat alfa
- corticorelin
- corticotropin
- cortisone
- cosyntropin
- cyclosporine
- idelalisib
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- interferon beta-1a
- interferon beta-1b
- isoniazid
- leflunomide
- levoketoconazole
- levothyroxine
- levothyroxine / liothyronine
- liothyronine
- liotrix
- lomitapide
- teriflunomide
- thioguanine
- thyroid desiccated
- tolazamide
- tolbutamide
- trabectedin
- triamcinolone
- triamcinolone ophthalmic
Durabolin alcohol/food interactions
There is 1 alcohol/food interaction with Durabolin (nandrolone).
Durabolin disease interactions
There are 10 disease interactions with Durabolin (nandrolone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- diabetes
- hypercalcemia
- thyroid function tests
Report options
More about Durabolin (nandrolone)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
FeroSul
FeroSul is used for anemia due to chronic kidney disease, iron deficiency anemia, vitamin/mineral ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.